Tekcapital #TEK – Portfolio Companies Update

Tekcapital Plc (AIM: TEK), the UK intellectual property investment group is pleased to provide a summary of latest developments across certain of its portfolio companies.  Belluscura  Belluscura plc (“Belluscura” AIM: BELL), announced on 16 August 2023 it has received purchase orders for over 6,500 of its next-generation DISCOV-R portable oxygen concentrator. This represents approximately US$15 […]

#TEK Capital investee company #BELL Belluscura PLC – Orders for over 6,500 DISCOV-R™ received

LONDON, U.K. AND PLANO, TX, U.S. (16 August 2023). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has received purchase orders for over 6,500 of its next-generation DISCOV-R portable oxygen concentrator. This represents approximately $15 million of potential revenue to the Company, with initial production of the DISCOV-R expected to […]

Poolbeg Pharma #POLB August 2023 – CEO Jeremy Skillington talks to Alan Green

Poolbeg CEO Jeremy Skillington talks to Alan Green in this August 2023 interview, and explains the company’s ‘capital light’ model that is giving the group a real market advantage. Jeremy then covers the developments this year with Poolbeg’s flagship POLB001 asset towards a blockbuster treatment for severe influenza, and the expansion of application into oncology […]

UKIM Podcast – CEO Alan Green discusses Apple, Amazon, and Harland & Wolff

Alan Green joins the Podcast to discuss Apple and Amazon’s earnings, and the US tech sector. We also provide and overview and analysis of Harland & Wolff. We discuss: Apple (NYSE:AAPL)) Amazon (NYSE:AMZN) Harland & Wolff (LON:HARL) Listen – https://ukinvestormagazine.co.uk/apple-amazon-and-harland-wolff-with-alan-green/

Quoted Micro 31 July 2023

AQUIS STOCK EXCHANGE Oberon Investments (OBE) reported a decline from £6.7m to £5m because of lower share dealing and capital markets income. The loss increased from £581,000 to £3.9m, which was predominantly down to one-off reorganisation and transaction costs. Management is confident that acquisitions and new teams will enable revenues to grow to more than […]